In the rapidly evolving landscape of modern biotechnology, the precision of molecular tools determines the speed of medical breakthroughs. As a Global Leading Biotinylated Peptide Synthesis specialist ...

On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug Administration has approved the company’s Volt™ PFA ...

Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.

In parallel with the tendered offer, PathoCare Holdings announced that-based on stronger-than-expected institutional interest and market demand-the Company is increasing the size of its contemplated ...

At Health First, this innovation is being brought to life through partners like NextGen Pathology, delivering precise diagnostic services.

Learn more about whether Charles River Laboratories International, Inc. or Thermo Fisher Scientific Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key ...

Learn more about whether Charles River Laboratories International, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

A Filipino expert in laboratory medicine has continued to draw recognition locally and abroad for work in Immunohematology and Transfusion Medicine, a field vital to patient safety and modern ...

In the U.S. there are more than 150 million emergency department (ED) visits each year, and the number is expected to rise. ED physicians face enormous pressure to quickly and correctly diagnose ...

Medome arose from a tragic loss. Dr. Steven Charlap, a physician and entrepreneur, lost his brother to a preventable cancer medical diagnosis error. These preventable events underscore a devastating ...

ALS is a debilitating paralytic disease characterized as the death of upper and lower motor neurons. Fortunately, ALS is relatively rare, with an incidence rate of 1.6 per 100,000 adults, resulting in ...

ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Point-of-care infectious disease diagnostics valued at $53 billion in ...